Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Scandinavian Journal of Infectious Diseases|June 16, 2011
AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responsesBelkis Romeu, Elizabeth González, Caridad Zayas, et al.
Canadian Journal of Microbiology|March 2, 2011
Mucosal and systemic immune responses of mice to tetanus toxoid coadministered nasally with AFCo1Belkis Romeu, Elyzabeth González, Judith Del Campo, et al.
Vaccine|July 11, 2006
Scale up of proteoliposome derived Cochleate productionCaridad Zayas, Gustavo Bracho, Miriam Lastre, et al.
Vaccine|July 11, 2006
Bacterial derived proteoliposome for allergy vaccinesMiriam Lastre, Oliver Pérez, Alexis Labrada, et al.
BMC Immunology|March 6, 2013
Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup BCaridad Zayas, Domingo González, Reinaldo Acevedo, et al.
Frontiers in Immunology|March 31, 2025
OligoDOM<sup>TM</sup>: a T-cell response-enhancing platform applied to cancer immunotherapyJudith Del Campo, Séverine Valsesia, Elsa Nikly, et al.
Immunology and Cell Biology|November 20, 2004
Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular patternOliver Pérez, Gustavo Bracho, Miriam Lastre, et al.
Methods (San Diego, Calif.)|June 24, 2009
Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in miceReinaldo Acevedo, Adriana Callicó, Judith del Campo, et al.
Frontiers in Immunology|June 28, 2021
OVX836 Heptameric Nucleoprotein Vaccine Generates Lung Tissue-Resident Memory CD8+ T-Cells for Cross-Protection Against InfluenzaJudith Del Campo, Julien Bouley, Marion Chevandier, et al.
Frontiers in Immunology|April 25, 2022
Randomized, Double-Blind, Reference-Controlled, Phase 2a Study Evaluating the Immunogenicity and Safety of OVX836, A Nucleoprotein-Based Influenza VaccineIsabel Leroux-Roels, Gwenn Waerlop, Jessika Tourneur, et al.
Pageof 3